Drug data last refreshed 5h ago · AI intelligence enriched 2w ago
HUMATROPE (somatropin) is a recombinant human growth hormone indicated for growth hormone deficiency and related conditions in children and adults. It is administered via subcutaneous injection and works by mimicking endogenous growth hormone to promote linear growth, protein synthesis, and metabolic function.
As LOE approaches, expect contraction in brand team size and shift toward lifecycle extension and generic defense strategies.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
The Efficacy and Safety of Inpegsomatropin Injection in Children With Turner Syndrome (TS) and Short Stature
Safety, Pharmacokinetic (PK) Profile and Efficacy of Inpegsomatropin Injection in Adults With Growth Hormone Deficiency
A Study to Learn How Different Injector Pens Affect the Study Medicine Called Genotropin (Somatropin) Delivery and Taken up Into the Blood in Healthy Adults
The Efficacy and Safety of Inpegsomatropin Injection in Children With Short Stature Born Small for Gestational Age
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Worked on HUMATROPE at Eli Lilly and Company? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on HUMATROPE offers experience in mature product management, payer negotiations, and biosimilar defense strategies within a legacy Eli Lilly franchise. Career progression will depend on contributing to lifecycle extension and market retention as LOE approaches.